Cannabis stocks jump after Trump endorses CBD for seniors

Why it matters: A new Truth Social video and statements from President Trump praising cannabidiol (CBD) for senior healthcare have revived hopes for U.S. cannabis rescheduling and Medicare coverage, sending U.S.-listed cannabis names and related plays sharply higher. Reuters reports premarket gains of ~20% in several cannabis stocks and a surge in the U.S. cannabis ETF.

WINNERS

Cannabis producers (U.S.-listed)

Reason: An endorsement tied to senior healthcare plus ongoing rescheduling chatter raises expectations for demand, tax relief from Section 280E, and easier access to U.S. capital markets.

Names: $TLRY (Tilray Brands), $CGC (Canopy Growth).

U.S. cannabis exposure via ETFs

Reason: Immedia ...